Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Réglementation et droit · 19/09/19961 min de lecture
Sperti Drug Products, Inc., et al.; Withdrawal of Approval of 40 New Drug Applications
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is withdrawing 40 new drug applications (NDA's). The basis for the withdrawals is that the holders of the applications have repeatedly failed to file required annual reports on these NDA's.
Langue originale de la source: Federal Register — All DocumentsOuvrir le communiqué original →